Catia Giovannini

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Top Venues

European journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Piscaglia Fabio, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response. Cancers 16 (4) (2024)
Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Piscaglia Fabio, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response. Cancers 16 (4) (2024)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Laura Gramantieri, Fabrizia Suzzi, Cristian Bassi, Lucilla D'Abundo, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Negrini, Massimo Iavarone, Piscaglia Fabio, Catia Giovannini
Circulating CD8 Lymphocytes Predict Response to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. European journal of immunology (2023)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Treré
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma. Biomolecules 12 (7) (2022)
Laura Gramantieri, Federica Gnudi, Francesco Vasuri, Daniele Mandrioli, Francesca Fornari, Francesco Tovoli, Fabrizia Suzzi, Andrea Vornoli, Antonia D'Errico, Piscaglia Fabio, Catia Giovannini
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area. Nutrients 14 (8) (2022)
Francesco Decataldo, Catia Giovannini, Laura Grumiro, Maria Michela Marino, Francesca Faccin, Martina Brandolini, Giorgio Dirani, Francesca Taddei, Davide Lelli, Marta Tessarolo, Maria Calienni, Carla Cacciotto, Alessandra Mistral De Pascali, Antonio Lavazza, Beatrice Fraboni, Vittorio Sambri, Alessandra Scagliarini
Organic Electrochemical Transistors as Versatile Tool for Real-Time and Automatized Viral Cytopathic Effect Evaluation. Viruses 14 (6) (2022)
Catia Giovannini, Francesca Fornari, Piscaglia Fabio, Laura Gramantieri
Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Cells 10 (3) (2021)
Giovannamaria Petrocelli, Fulvia Farabegoli, Maria Chiara Valerii, Catia Giovannini, Alberto Sardo, Enzo Spisni
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC). Molecules (Basel, Switzerland) 26 (4) (2021)
Laura Gramantieri, Catia Giovannini, Fabrizia Suzzi, Ilaria Leoni, Francesca Fornari
Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers. Cancers 13 (18) (2021)
Catia Giovannini, Francesca Fornari, Valentina Indio, Davide Treré, Matteo Renzulli, Francesco Vasuri, Matteo Cescon, Matteo Ravaioli, Alessia Perrucci, Annalisa Astolfi, Fabio Piscaglia, Laura Gramantieri
Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma. Cancers 12 (9) (2020)